Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Interactions
  4. Women's Health
  5. Raloxifene

Raloxifene

  • Bone & Joint (51)
  • Cardiology (196)
  • Dermatology (49)
  • Diabetes & Endocrinology (41)
  • Gastroenterology (58)
  • Hematology & Oncology (6)
  • Infectious Diseases (187)
  • Men's Health (4)
  • Natural Medicines / Supplements / Food Interactions (127)
  • Neurology (112)
  • Nutrition & Obesity (8)
  • Psychiatry (115)
  • Resources (35)
  • Respiratory & Allergy (14)
  • Rheumatology (1)
  • Transplant Meds (14)
  • Women's Health (45)
    • Oral Contraceptives (39)
    • Raloxifene (7)
1 - 7 of 7 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
FAQ: Meds to Prevent Breast Cancer: FAQs November 2019
Chart: Comparison of Angiotensin Receptor Blockers (ARBs) September 2018
Article: Keep Supplement Interactions on Your Radar May 2016
Article: more high-risk women on drug therapy for prevention of breast cancer September 2013
Article: Experts are warning about intestinal problems linked to the "ARB" blood pressure med, olmesartan (Olmetec) September 2013
Other: Breast Cancer Risk Calculator September 2013
Commentary: Olmesartan and Severe Intestinal Problems September 2013
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved